Information:
Fel:
ID
20680
Beskrivning
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00391209
Länk
https://clinicaltrials.gov/show/NCT00391209
Nyckelord
Versioner (1)
- 2017-03-10 2017-03-10 -
Uppladdad den
10 mars 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Type 2 NCT00391209
Eligibility Diabetes Mellitus, Type 2 NCT00391209
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00391209
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes mellitus for at least 6 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Glycosylated hemoglobin A Percentage
Item
have a hba1c greater than 7.0% and less than or equal to 10.5% at screening.
boolean
C0019018 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,2])
Therapeutic procedure
Item
patients who have been treated with the following regimen:
boolean
C0087111 (UMLS CUI [1])
Oral hypoglycemic Quantity Dose Stable | Thiazolidinediones
Item
one or more oral antihyperglycemic medications on a stable dose for at least 6 weeks (12 weeks for thiazolidinediones [tzds]),
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
C1257987 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
C1257987 (UMLS CUI [2])
Insulin Period Lifetime | Insulin Discontinued
Item
have been on insulin for 14 days or less throughout life and have not taken insulin within 6 months,
boolean
C0021641 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
C4071830 (UMLS CUI [1,3])
C0021641 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1948053 (UMLS CUI [1,2])
C4071830 (UMLS CUI [1,3])
C0021641 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
Indication Insulin regime
Item
are candidates for insulin therapy, in the opinion of the investigator.
boolean
C3146298 (UMLS CUI [1,1])
C0557978 (UMLS CUI [1,2])
C0557978 (UMLS CUI [1,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Tobacco use
Item
smoker
boolean
C0543414 (UMLS CUI [1])
Hypoglycemia Severe Episode Quantity
Item
history of more than two episodes of severe hypoglycemia during the 6 months prior to study entry
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Pneumonia
Item
diagnosed with pneumonia in the 3 months prior to screening
boolean
C0032285 (UMLS CUI [1])
Glucocorticoids, Systemic
Item
patients who have received systemic glucocorticoid therapy within 3 months prior to study entry
boolean
C3540777 (UMLS CUI [1])
Kidney Transplantation
Item
history of renal transplantation
boolean
C0022671 (UMLS CUI [1])
Lung Transplantation
Item
history of lung transplantation
boolean
C0024128 (UMLS CUI [1])
Malignant Neoplasm | Malignant Neoplasm untreated
Item
active or untreated malignancy
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0006826 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Incretin mimetic product
Item
treated with incretin mimetics
boolean
C1562104 (UMLS CUI [1])